COMMUNITY ACQUIRED PNEUMONIA (CAP)
Clinical trials for COMMUNITY ACQUIRED PNEUMONIA (CAP) explained in plain language.
Never miss a new study
Get alerted when new COMMUNITY ACQUIRED PNEUMONIA (CAP) trials appear
Sign up with your email to follow new studies for COMMUNITY ACQUIRED PNEUMONIA (CAP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New plan aims to curb unneeded antibiotics for Kids' pneumonia
Disease control Not yet recruitingThis study aims to test a new care plan to help doctors decide when antibiotics are truly needed for children with mild pneumonia. It will enroll about 700 children in emergency rooms who are well enough to go home. The goal is to safely reduce unnecessary antibiotic prescription…
Matched conditions: COMMUNITY ACQUIRED PNEUMONIA (CAP)
Phase: NA • Sponsor: Jeffrey Pernica • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
First human tests begin for new sepsis drug
Disease control Not yet recruitingThis is an early safety study for a new drug called OPT101, designed for adults hospitalized with pneumonia that has led to sepsis. The main goal is to see if the drug is safe and how it moves through the body in this seriously ill group. Researchers will compare the drug to a pl…
Matched conditions: COMMUNITY ACQUIRED PNEUMONIA (CAP)
Phase: PHASE1 • Sponsor: Op-T LLC • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
New genetic test could help doctors fix failed pneumonia treatments faster
Diagnosis Not yet recruitingThis study is testing whether a new, more detailed genetic test can help doctors treat hospitalized pneumonia patients who aren't getting better with their initial antibiotics. Researchers will compare patients who get this advanced test to those who get standard tests to see if …
Matched conditions: COMMUNITY ACQUIRED PNEUMONIA (CAP)
Phase: NA • Sponsor: Capital Medical University • Aim: Diagnosis
Last updated Mar 30, 2026 14:27 UTC